idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
11.12.2025 09:43

New vulnerability of asthma immune cells discovered

Jana Schäfer Kommunikation und Medien
Universitätsklinikum Bonn

    Bonn, December 10, 2025 – Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of Bonn has discovered that these cells only survive because they activate a special antioxidant protection mechanism. When this mechanism is blocked, allergic inflammation in mouse models decreases significantly. The results have now been published in the scientific journal Immunity.

    In allergic asthma, so-called ILC2 and Th2 cells are key drivers of inflammation. They produce messenger substances that increase mucus formation and the influx of immune cells. At the same time, the inflamed lung tissue is rich in free fatty acids and oxidative molecules - conditions that normally endanger cells.

    The study shows that pathogenic ILC2s absorb large amounts of these fats and incorporate them into their membranes. In order to avoid dying from ferroptosis, an iron-dependent form of cell death caused by oxidized lipids, they activate their antioxidant systems. The enzymes GPX4 and TXNRD1 play a central role in this process. They neutralize harmful lipid peroxides and enable the cells to survive and multiply despite the stressful environment.

    “These immune cells operate in an environment that is actually toxic to them. They only survive because they ramp up their own protective programs to an extreme degree,” explains first author Chantal Wientjens, who conducts research in the Wilhelm working group at the Institute of Chemistry and Clinical Pharmacology at the UKB and is a doctoral student at the University of Bonn. “Our data show that as soon as we specifically disrupt this protection, the cells lose their ability to drive allergic inflammation.”

    To test this approach, the Bonn team inhibited the thioredoxin metabolic pathway using a drug that blocks the enzyme TXNRD1. In mouse models, this led to significantly less ILC2 accumulating in the lungs. As a result, both the production of the typical type 2 cytokines IL-5 and IL-13 and the number of eosinophils and mucus production decreased. Overall, the allergic reaction was significantly less severe.

    Study leader Christoph Wilhelm, Chair of Immunopathology at the Institute for Clinical Chemistry and Clinical Pharmacology at the UKB and member of the ImmunoSensation² Cluster of Excellence at the University of Bonn, explains: "Pathogenic type 2 immune cells are surprisingly dependent on their antioxidant ‘lifeline’. This opens up a new therapeutic venue: In the future, we could slow down the metabolism of overactive immune cells without weakening the immune system as a whole. This is an exciting prospect, even though we are still in the early stages of research."

    The study underscores how closely immune function and metabolism are intertwined. In order to remain active in the high-fat and oxidative environment of the inflamed lung, pathogenic ILC2s flexibly adapt their metabolism - and in doing so, unintentionally create the very dependency that makes them vulnerable.

    Participating institutions and funding:
    The University Hospital Bonn, the ImmunosenSation2 Cluster of Excellence at the University of Bonn, and the Collaborative Research Center (S)FB Metaflammation were involved in the study. The study was funded by the DFG.


    Wissenschaftliche Ansprechpartner:

    Prof. Christoph Wilhelm
    Institute for Clinical Chemistry and Clinical Pharmacology at the UKB
    ImmunoSensation² Cluster of Excellence at the University of Bonn
    Email: Christoph.Wilhelm@ukbonn.de


    Originalpublikation:

    Wientjens C, Doverman M, Zurkovic J, More T, Surendar J, Nesic S, Sarici C, Utecht T. D., Pohl J, Pollock J, Voehringer D, Hiller K, Thiele C and Wilhelm C. Tolerance to ferroptosis facilitates lipid metabolism and pathogenic type 2 immunity in allergic airway inflammation. Immunity 2026; 59 1-17. DOI: https://doi.org/10.1016/j.immuni.2025.11.018


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten
    Medizin
    überregional
    Forschungsergebnisse
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).